Previous Section
Radioiodine Therapy
1. Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage.
- Author
- Hernandez-Jimenez S; Pachon-Burgos A; Aguilar-Salinas CA; Andrade V; Reynoso R; Rios A; Reza-Albarran AA; Mehta R; Gonzalez-Trevino O; Gomez-Perez FJ; Perez-Enriquezi B; Rull JA;
- Institution
- Departamento de Endocrinologia y Metabolismo, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico. sergiohdzj@hotmail.com
- Journal
- Arch Med Res. 2007 Feb;38(2):185-9.
- Abstract URL
- Click here to view abstract
2. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
- Author
- Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J;
- Institution
- Department of Internal Medicine, Tampere University Hospital, Tampere, Finland; Medical School, University of Tampere; Tampere School of Public Health, University of Tampere; Research Unit, Tampere University Hospital, Tampere, Finland; STUK-Radiation and Nuclear Safety Authority, Research and Environmental Surveillance, Helsinki, Finland.
- Journal
- J Clin Endocrinol Metab. 2007 Mar 20;.
- Abstract URL
- Click here to view abstract
3. Testicular function after 131I therapy for hyperthyroidism.
- Author
- Ceccarelli C; Canale D; Battisti P; Caglieresi C; Moschini C; Fiore E; Grasso L; Pinchera A; Vitti P;
- Institution
- Department of Endocrinology, University of Pisa, Pisa, Italy. claudiac@endoc.med.unipi.it
- Journal
- Clin Endocrinol (Oxf). 2006 Oct;65(4):446-52.
- Abstract URL
- Click here to view abstract
4. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
- Author
- Vijayakumar V; Ali S; Nishino T; Nusynowitz M;
- Institution
- Nuclear Medicine Section, Department of Radiology, University of Texas Medical Branch, Galveston, TX 77555-0793, USA. vavijaya@utmb.edu
- Journal
- Clin Nucl Med. 2006 Nov;31(11):688-9.
- Abstract URL
- Click here to view abstract
5. Endocrine ophthalmopathy and radioiodine therapy.
- Author
- Karlsson FA;
- Institution
- Section of Endocrinology and Diabetes, Institute of Medical Sciences, Uppsala University Hospital, Uppsala, S-751 85, Uppsala, Sweden. anders.karlsson@medsci.uu.se
- Journal
- Acta Oncol. 2006;45(8):1046-50.
- Abstract URL
- Click here to view abstract
Next: Graves' Ophthalmopathy
